73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
Vorträge Montag, 30.05.2022
Experimentelle Neuroonkologie I/Experimental neurooncology I
Meeting Abstract
(V075)
[Volltext]
Establishment of a reliable Glioblastoma Tumor-Organoid platform enables automated high-throughput drug screening advancing personalised medicine
Jungwirth G, Paul A, Cao J, Warta R, Abdollahi A, Unterberg AW, Herold-Mende C[Volltext]
Meeting Abstract
(V076)
[Volltext]
PLOD2 is an independent prognostic marker and molecular mediator in glioblastoma
Kreße N, Schröder H, Stein KP, Mawrin C, Dumitru CA, Sandalcioglu IE[Volltext]
Meeting Abstract
(V078)
[Volltext]
Spatially resolved transcriptomics and metabolomics uncover hypoxia-driven accumulation of genomic instabilities in human glioma
Kückelhaus J, Will P, Ricklefs FL, Kada Benotmane J, Joseph K, Beck J, Schnell O, M. Ravi V, Heiland DH[Volltext]
Meeting Abstract
(V079)
[Volltext]
Personalised therapeutic approach in translational neuro-oncology – JAK/STAT inhibition reverses the anti-tumour immunity induced by myeloid cells in T cells
Ravi VM, Neidert N, Joseph K, Beck J, Schnell O, Heiland DH[Volltext]
Meeting Abstract
(V080)
[Volltext]
Mechanisms of Cytomegalovirus to tumour transmission across the blood-brain barrier in glioblastoma
Krenzlin H, Schmidt L, Berenz T, Lemmermann N, Lawler S, Ringel F, Keric N[Volltext]
Meeting Abstract
(V081)
[Volltext]
Mitochondrial 2-oxo-dehydrogenase complexes as a target for the therapy of glioblastomas
Seidenstücker T, Meixensberger J, Gaunitz F[Volltext]
Meeting Abstract
(V082)
[Volltext]
FTY720 (Fingolimod) has an antiproliferative effect on human Glioblastoma cells alone and in combination with Temozolomide but does not influence the expression of EMT-related genes
Gött H, Nagl J, Santhiyanesan S, Seemann C, Schwarm FP, Uhl E, Stein M, Kolodziej MA[Volltext]
